Evidence map›Paper›PMID 34404441›Full record

ArticleRadiation oncology (London, England)2021

Deep learning method for prediction of patient-specific dose distribution in breast cancer.

Sang Hee Ahn, EunSook Kim, Chankyu Kim, Wonjoong Cheon, Myeongsoo Kim, Se Byeong Lee, Young Kyung Lim, Haksoo Kim, Dongho Shin, Dae Yong Kim and 1 more

Open access · goldAbstract read
In one paragraph

Article in Radiation oncology (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
17.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 91 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Sang Hee AhnDepartment of Radiation Oncology, Proton Therapy Center, National Cancer Center, 323, Ilsan-ro, Ilsandong-guGyeonggi-do, Goyang-si, 10408, South Korea.
EunSook KimDepartment of Radiation Oncology, Proton Therapy Center, National Cancer Center, 323, Ilsan-ro, Ilsandong-guGyeonggi-do, Goyang-si, 10408, South Korea.
Chankyu KimDepartment of Radiation Oncology, Proton Therapy Center, National Cancer Center, 323, Ilsan-ro, Ilsandong-guGyeonggi-do, Goyang-si, 10408, South Korea.
Wonjoong CheonDepartment of Radiation Oncology, Proton Therapy Center, National Cancer Center, 323, Ilsan-ro, Ilsandong-guGyeonggi-do, Goyang-si, 10408, South Korea.
Myeongsoo KimDepartment of Radiation Oncology, Proton Therapy Center, National Cancer Center, 323, Ilsan-ro, Ilsandong-guGyeonggi-do, Goyang-si, 10408, South Korea.
Se Byeong LeeDepartment of Radiation Oncology, Proton Therapy Center, National Cancer Center, 323, Ilsan-ro, Ilsandong-guGyeonggi-do, Goyang-si, 10408, South Korea.
Young Kyung LimDepartment of Radiation Oncology, Proton Therapy Center, National Cancer Center, 323, Ilsan-ro, Ilsandong-guGyeonggi-do, Goyang-si, 10408, South Korea.
Haksoo KimDepartment of Radiation Oncology, Proton Therapy Center, National Cancer Center, 323, Ilsan-ro, Ilsandong-guGyeonggi-do, Goyang-si, 10408, South Korea.
Dongho ShinDepartment of Radiation Oncology, Proton Therapy Center, National Cancer Center, 323, Ilsan-ro, Ilsandong-guGyeonggi-do, Goyang-si, 10408, South Korea.
Dae Yong KimDepartment of Radiation Oncology, Proton Therapy Center, National Cancer Center, 323, Ilsan-ro, Ilsandong-guGyeonggi-do, Goyang-si, 10408, South Korea.
Jong Hwi JeongDepartment of Radiation Oncology, Proton Therapy Center, National Cancer Center, 323, Ilsan-ro, Ilsandong-guGyeonggi-do, Goyang-si, 10408, South Korea. jonghwi@ncc.re.kr.
National Cancer Center · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatient-specific dose prediction improves the efficiency and quality of radiation treatment planning and reduces the time required to find the optimal plan. In this study, a patient-specific dose prediction model was developed for a left-sided breast clinical case using deep learning, and its performance was compared with that of conventional knowledge-based planning using RapidPlan™.

methodsPatient-specific dose prediction was performed using a contour image of the planning target volume (PTV) and organs at risk (OARs) with a U-net-based modified dose prediction neural network. A database of 50 volumetric modulated arc therapy (VMAT) plans for left-sided breast cancer patients was utilized to produce training and validation datasets. The dose prediction deep neural network (DpNet) feature weights of the previously learned convolution layers were applied to the test on a cohort of 10 test sets. With the same patient data set, dose prediction was performed for the 10 test sets after training in RapidPlan. The 3D dose distribution, absolute dose difference error, dose-volume histogram, 2D gamma index, and iso-dose dice similarity coefficient were used for quantitative evaluation of the dose prediction.

resultsThe mean absolute error (MAE) and one standard deviation (SD) between the clinical and deep learning dose prediction models were 0.02 ± 0.04%, 0.01 ± 0.83%, 0.16 ± 0.82%, 0.52 ± 0.97, - 0.88 ± 1.83%, - 1.16 ± 2.58%, and - 0.97 ± 1.73% for D

conclusionsIn this study, a deep learning method for dose prediction was developed and was demonstrated to accurately predict patient-specific doses for left-sided breast cancer. Using the deep learning framework, the efficiency and accuracy of the dose prediction were compared to those of RapidPlan. The doses predicted by deep learning were superior to the results of the RapidPlan-generated VMAT plan.

Indexed as

Deep LearningBreast NeoplasmsFemaleHumansMiddle AgedOrgans at RiskRadiotherapy DosageRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedDeep learningDose predictionKnowledge-based planning (KBP)RapidPlan™Volumetric modulated arc therapy (VMAT)

Identifiers

PMID34404441
PMCPMC8369791
OpenAlexW3124760540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.